Found: 17
Select item for more details and to access through your institution.
Clinical commentary on “De novo convulsive status epilepticus in patients with multiple sclerosis treated with dalfampridine”.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 621, doi. 10.1177/1352458518810661
- By:
- Publication type:
- Article
Enhancing natural killer cells is beneficial in multiple sclerosis – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 513, doi. 10.1177/1352458518809296
- By:
- Publication type:
- Article
Multidisciplinary data infrastructures in multiple sclerosis: Why they are needed and can be done!
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 500, doi. 10.1177/1352458518807076
- By:
- Publication type:
- Article
The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 515, doi. 10.1177/1352458518757089
- By:
- Publication type:
- Article
Enhancing natural killer cells is beneficial in multiple sclerosis – No.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 512, doi. 10.1177/1352458518799591
- By:
- Publication type:
- Article
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 565, doi. 10.1177/1352458518763089
- By:
- Publication type:
- Article
De novo convulsive status epilepticus in patients with multiple sclerosis treated with dalfampridine.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 618, doi. 10.1177/1352458518790379
- By:
- Publication type:
- Article
Neuraxial analgesia is not associated with an increased risk of post-partum relapses in MS.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 591, doi. 10.1177/1352458518763080
- By:
- Publication type:
- Article
Enhancing natural killer cells is beneficial in multiple sclerosis – Yes.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 510, doi. 10.1177/1352458518800776
- By:
- Publication type:
- Article
Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 585, doi. 10.1177/1352458518761186
- By:
- Publication type:
- Article
The role of the thalamus and hippocampus in episodic memory performance in patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 574, doi. 10.1177/1352458518760716
- By:
- Publication type:
- Article
Convergent effects of a functional C3 variant on brain atrophy, demyelination, and cognitive impairment in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 532, doi. 10.1177/1352458518760715
- By:
- Publication type:
- Article
Multiple sclerosis–related fatigue: Altered resting-state functional connectivity of the ventral striatum and dorsolateral prefrontal cortex.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 554, doi. 10.1177/1352458518758911
- By:
- Publication type:
- Article
Online meditation training for people with multiple sclerosis: A randomized controlled trial.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 610, doi. 10.1177/1352458518761187
- By:
- Publication type:
- Article
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 523, doi. 10.1177/1352458518758927
- By:
- Publication type:
- Article
Safety and efficacy of ADS-5102 (amantadine) extended release capsules to improve walking in multiple sclerosis: A randomized, placebo-controlled, phase 2 trial.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 601, doi. 10.1177/1352458518754716
- By:
- Publication type:
- Article
Pathological cut-offs of global and regional brain volume loss in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 4, p. 541, doi. 10.1177/1352458517742739
- By:
- Publication type:
- Article